Click here to get full coverage on Verona Pharma plc (VRNA) Is Unlikely To Face Antitrust Action For Merck Deal, Says Jim Cramer - Yahoo Finance

Verona Pharma plc (VRNA) Is Unlikely To Face Antitrust Action For Merck Deal, Says Jim Cramer  Yahoo Finance

Verona Pharma plc (VRNA) Is Unlikely To Face Antitrust Action For Merck Deal, Says Jim Cramer - Yahoo Finance

Click here to get full coverage on All You Need to Know About Verona Pharma (VRNA) Rating Upgrade to Buy - Nasdaq

All You Need to Know About Verona Pharma (VRNA) Rating Upgrade to Buy  Nasdaq

All You Need to Know About Verona Pharma (VRNA) Rating Upgrade to Buy - Nasdaq

Click here to get full coverage on Metabolic interference impairs influenza A virus replication by dampening vRNA synthesis - Nature

Metabolic interference impairs influenza A virus replication by dampening vRNA synthesis  Nature

Metabolic interference impairs influenza A virus replication by dampening vRNA synthesis - Nature

Click here to get full coverage on VERONA PHARMA Earnings Results: $VRNA Reports Quarterly Earnings - Quiver Quantitative

VERONA PHARMA Earnings Results: $VRNA Reports Quarterly Earnings  Quiver Quantitative

VERONA PHARMA Earnings Results: $VRNA Reports Quarterly Earnings - Quiver Quantitative

Click here to get full coverage on Verona Pharma (VRNA) director Deschamps sells $124,391 in shares - Investing.com

Verona Pharma (VRNA) director Deschamps sells $124,391 in shares  Investing.com

Verona Pharma (VRNA) director Deschamps sells $124,391 in shares - Investing.com

Click here to get full coverage on Volatility-Proof Your Portfolio With VIPS, GDS, FUTU & VRNA Stocks - Zacks Investment Research

Volatility-Proof Your Portfolio With VIPS, GDS, FUTU & VRNA Stocks  Zacks Investment Research

Volatility-Proof Your Portfolio With VIPS, GDS, FUTU & VRNA Stocks - Zacks Investment Research

Click here to get full coverage on Verona Pharma plc (VRNA): Jim Cramer Approves The Merck Acquisition - Yahoo Finance

Verona Pharma plc (VRNA): Jim Cramer Approves The Merck Acquisition  Yahoo Finance

Verona Pharma plc (VRNA): Jim Cramer Approves The Merck Acquisition - Yahoo Finance

Click here to get full coverage on Direct detection of 4-dimensions of SARS-CoV-2: infection (vRNA), infectivity (antigen), binding antibody, and functional neutralizing antibody in saliva - Nature

Direct detection of 4-dimensions of SARS-CoV-2: infection (vRNA), infectivity (antigen), binding antibody, and functional neutralizing antibody in saliva  Nature

Direct detection of 4-dimensions of SARS-CoV-2: infection (vRNA), infectivity (antigen), binding antibody, and functional neutralizing antibody in saliva - Nature

Click here to get full coverage on Verona Pharma (VRNA) director Ackermann sells $24k in shares - Investing.com

Verona Pharma (VRNA) director Ackermann sells $24k in shares  Investing.com

Verona Pharma (VRNA) director Ackermann sells $24k in shares - Investing.com

Click here to get full coverage on Volatility-Proof Your Portfolio With VIPS, GDS, FUTU & VRNA Stocks - Yahoo Finance

Volatility-Proof Your Portfolio With VIPS, GDS, FUTU & VRNA Stocks  Yahoo Finance

Volatility-Proof Your Portfolio With VIPS, GDS, FUTU & VRNA Stocks - Yahoo Finance

Click here to get full coverage on Piper Sandler Lifts PT on Verona Pharma (VRNA) Stock, Maintains Overweight - Yahoo Finance

Piper Sandler Lifts PT on Verona Pharma (VRNA) Stock, Maintains Overweight  Yahoo Finance

Piper Sandler Lifts PT on Verona Pharma (VRNA) Stock, Maintains Overweight - Yahoo Finance

Click here to get full coverage on Jefferies Backs Verona Pharma plc (VRNA) After Strong Ohtuvayre Launch - Yahoo Finance

Jefferies Backs Verona Pharma plc (VRNA) After Strong Ohtuvayre Launch  Yahoo Finance

Jefferies Backs Verona Pharma plc (VRNA) After Strong Ohtuvayre Launch - Yahoo Finance

Click here to get full coverage on Merck's VRNA Buyout to Add Novel COPD Therapy: How to Play the Stock? - Yahoo Finance

Merck's VRNA Buyout to Add Novel COPD Therapy: How to Play the Stock?  Yahoo Finance

Merck's VRNA Buyout to Add Novel COPD Therapy: How to Play the Stock? - Yahoo Finance

Click here to get full coverage on Here's Why Momentum in Verona Pharma (VRNA) Should Keep going - Yahoo Finance

Here's Why Momentum in Verona Pharma (VRNA) Should Keep going  Yahoo Finance

Here's Why Momentum in Verona Pharma (VRNA) Should Keep going - Yahoo Finance

Click here to get full coverage on Jim Cramer Notes Verona Pharma plc (VRNA) “Loses a Lot of Money” - Yahoo Finance

Jim Cramer Notes Verona Pharma plc (VRNA) “Loses a Lot of Money”  Yahoo Finance

Jim Cramer Notes Verona Pharma plc (VRNA) “Loses a Lot of Money” - Yahoo Finance

Click here to get full coverage on Verona Pharma PLC (VRNA) Q4 2024 Earnings Call Highlights: Strong Launch of Ohtuvayre Amid ... - Yahoo Finance

Verona Pharma PLC (VRNA) Q4 2024 Earnings Call Highlights: Strong Launch of Ohtuvayre Amid ...  Yahoo Finance

Verona Pharma PLC (VRNA) Q4 2024 Earnings Call Highlights: Strong Launch of Ohtuvayre Amid ... - Yahoo Finance

Click here to get full coverage on Verona Pharma PLC (VRNA) Q1 2025 Earnings Call Highlights: Strong Ohtuvayre Sales Propel ... - Yahoo Finance

Verona Pharma PLC (VRNA) Q1 2025 Earnings Call Highlights: Strong Ohtuvayre Sales Propel ...  Yahoo Finance

Verona Pharma PLC (VRNA) Q1 2025 Earnings Call Highlights: Strong Ohtuvayre Sales Propel ... - Yahoo Finance

Click here to get full coverage on Why Verona Pharma plc (VRNA) is Among the Best Performing Healthcare Stocks to Buy Now - Yahoo Finance

Why Verona Pharma plc (VRNA) is Among the Best Performing Healthcare Stocks to Buy Now  Yahoo Finance

Why Verona Pharma plc (VRNA) is Among the Best Performing Healthcare Stocks to Buy Now - Yahoo Finance

Click here to get full coverage on SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VRNA, GNTY, MRC on Behalf of Shareholders - PR Newswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VRNA, GNTY, MRC on Behalf of Shareholders  PR Newswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VRNA, GNTY, MRC on Behalf of Shareholders - PR Newswire

Click here to get full coverage on Wall Street Analysts Predict a 25.99% Upside in Verona Pharma (VRNA): Here's What You Should Know - Nasdaq

Wall Street Analysts Predict a 25.99% Upside in Verona Pharma (VRNA): Here's What You Should Know  Nasdaq

Wall Street Analysts Predict a 25.99% Upside in Verona Pharma (VRNA): Here's What You Should Know - Nasdaq

Click here to get full coverage on Verona Pharma plc (VRNA): The Best Performing Pharma Stock So Far in 2025? - Yahoo Finance

Verona Pharma plc (VRNA): The Best Performing Pharma Stock So Far in 2025?  Yahoo Finance

Verona Pharma plc (VRNA): The Best Performing Pharma Stock So Far in 2025? - Yahoo Finance

Click here to get full coverage on Is VRNA stock a hidden gem - July 2025 Breakouts & Fast Exit Strategy with Risk Control - 뉴스임팩트

Is VRNA stock a hidden gem - July 2025 Breakouts & Fast Exit Strategy with Risk Control  뉴스임팩트

Is VRNA stock a hidden gem - July 2025 Breakouts & Fast Exit Strategy with Risk Control - 뉴스임팩트

Click here to get full coverage on How to Play Verona Pharma (VRNA) Stock After Merck’s Acquisition Announcement - Money Morning

How to Play Verona Pharma (VRNA) Stock After Merck’s Acquisition Announcement  Money Morning

How to Play Verona Pharma (VRNA) Stock After Merck’s Acquisition Announcement - Money Morning

Click here to get full coverage on Roth Capital Hikes Verona Pharma’s (VRNA) Price Target to $116 On COPD Market Prospects - Yahoo Finance

Roth Capital Hikes Verona Pharma’s (VRNA) Price Target to $116 On COPD Market Prospects  Yahoo Finance

Roth Capital Hikes Verona Pharma’s (VRNA) Price Target to $116 On COPD Market Prospects - Yahoo Finance

Click here to get full coverage on Here's Why 'Trend' Investors Would Love Betting on Verona Pharma (VRNA) - Yahoo Finance

Here's Why 'Trend' Investors Would Love Betting on Verona Pharma (VRNA)  Yahoo Finance

Here's Why 'Trend' Investors Would Love Betting on Verona Pharma (VRNA) - Yahoo Finance

Click here to get full coverage on VRNA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Verona Pharma plc Is Fair to Shareholders - Business Wire

VRNA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Verona Pharma plc Is Fair to Shareholders  Business Wire

VRNA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Verona Pharma plc Is Fair to Shareholders - Business Wire

Click here to get full coverage on Verona Pharma (VRNA) Opinions on Merck Acquisition News - Quiver Quantitative

Verona Pharma (VRNA) Opinions on Merck Acquisition News  Quiver Quantitative

Verona Pharma (VRNA) Opinions on Merck Acquisition News - Quiver Quantitative

Click here to get full coverage on Verona Pharma plc (VRNA): Among the Best Multibagger Stocks to Buy According to Billionaires - Yahoo Finance

Verona Pharma plc (VRNA): Among the Best Multibagger Stocks to Buy According to Billionaires  Yahoo Finance

Verona Pharma plc (VRNA): Among the Best Multibagger Stocks to Buy According to Billionaires - Yahoo Finance

Click here to get full coverage on SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VBTX, HMST, VRNA, STR on Behalf of Shareholders - PR Newswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VBTX, HMST, VRNA, STR on Behalf of Shareholders  PR Newswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VBTX, HMST, VRNA, STR on Behalf of Shareholders - PR Newswire

Click here to get full coverage on Is Verona Pharma (VRNA) Among Billionaire Joseph Edelman’s Long-Term Stock Picks? - Yahoo Finance

Is Verona Pharma (VRNA) Among Billionaire Joseph Edelman’s Long-Term Stock Picks?  Yahoo Finance

Is Verona Pharma (VRNA) Among Billionaire Joseph Edelman’s Long-Term Stock Picks? - Yahoo Finance

Click here to get full coverage on Biggest stock movers Wednesday: VRNA, WPP, AEHR, EVTL, RXST, BTCS and more - Seeking Alpha

Biggest stock movers Wednesday: VRNA, WPP, AEHR, EVTL, RXST, BTCS and more  Seeking Alpha

Biggest stock movers Wednesday: VRNA, WPP, AEHR, EVTL, RXST, BTCS and more - Seeking Alpha

Click here to get full coverage on What is the next catalyst for VRNA - Bullish Engulfing Trade Alerts - thegnnews.com

What is the next catalyst for VRNA - Bullish Engulfing Trade Alerts  thegnnews.com

What is the next catalyst for VRNA - Bullish Engulfing Trade Alerts - thegnnews.com

Click here to get full coverage on Earnings To Watch: Verona Pharma PLC (VRNA) Reports Q4 2024 Result - Yahoo Finance

Earnings To Watch: Verona Pharma PLC (VRNA) Reports Q4 2024 Result  Yahoo Finance

Earnings To Watch: Verona Pharma PLC (VRNA) Reports Q4 2024 Result - Yahoo Finance

Click here to get full coverage on Is Verona Pharma plc (VRNA) the Best Performing Growth Stock in 2025? - Yahoo Finance

Is Verona Pharma plc (VRNA) the Best Performing Growth Stock in 2025?  Yahoo Finance

Is Verona Pharma plc (VRNA) the Best Performing Growth Stock in 2025? - Yahoo Finance

Click here to get full coverage on Verona Pharma: An Impressive Initial Launch (NASDAQ:VRNA) - Seeking Alpha

Verona Pharma: An Impressive Initial Launch (NASDAQ:VRNA)  Seeking Alpha

Verona Pharma: An Impressive Initial Launch (NASDAQ:VRNA) - Seeking Alpha

Click here to get full coverage on This Just In: Analysts Are Boosting Their Verona Pharma plc (NASDAQ:VRNA) Outlook for This Year - simplywall.st

This Just In: Analysts Are Boosting Their Verona Pharma plc (NASDAQ:VRNA) Outlook for This Year  simplywall.st

This Just In: Analysts Are Boosting Their Verona Pharma plc (NASDAQ:VRNA) Outlook for This Year - simplywall.st

Click here to get full coverage on Verona Pharma Stock (VRNA) Soars 20% on $10B Merck Deal - TipRanks

Verona Pharma Stock (VRNA) Soars 20% on $10B Merck Deal  TipRanks

Verona Pharma Stock (VRNA) Soars 20% on $10B Merck Deal - TipRanks

Click here to get full coverage on Decoding Verona Pharma PLC (VRNA): A Strategic SWOT Insight - GuruFocus

Decoding Verona Pharma PLC (VRNA): A Strategic SWOT Insight  GuruFocus

Decoding Verona Pharma PLC (VRNA): A Strategic SWOT Insight - GuruFocus

Click here to get full coverage on Verona Pharma PLC (VRNA) Q1 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance

Verona Pharma PLC (VRNA) Q1 2025: Everything You Need To Know Ahead Of Earnings  Yahoo Finance

Verona Pharma PLC (VRNA) Q1 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance

Click here to get full coverage on VERONA PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verona Pharma plc - VRNA - Business Wire

VERONA PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verona Pharma plc - VRNA  Business Wire

VERONA PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verona Pharma plc - VRNA - Business Wire

Click here to get full coverage on Merck to Acquire Verona Pharma, Expanding its Portfolio to Include Ohtuvayre® (ensifentrine), a First-In-Class COPD Maintenance Treatment for Adults and Expected to Drive Growth into the Next Decade - Business Wire

Merck to Acquire Verona Pharma, Expanding its Portfolio to Include Ohtuvayre® (ensifentrine), a First-In-Class COPD Maintenance Treatment for Adults and Expected to Drive Growth into the Next Decade  Business Wire

Merck to Acquire Verona Pharma, Expanding its Portfolio to Include Ohtuvayre® (ensifentrine), a First-In-Class COPD Maintenance Treatment for Adults and Expected to Drive Growth into the Next Decade - Business Wire

Click here to get full coverage on $HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger: VRNA, BPMC, DALN, and RGLD - Morningstar

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger: VRNA, BPMC, DALN, and RGLD  Morningstar

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger: VRNA, BPMC, DALN, and RGLD - Morningstar

Click here to get full coverage on What Makes Verona Pharma PLC American Depositary Share (VRNA) a Strong Momentum Stock: Buy Now? - Nasdaq

What Makes Verona Pharma PLC American Depositary Share (VRNA) a Strong Momentum Stock: Buy Now?  Nasdaq

What Makes Verona Pharma PLC American Depositary Share (VRNA) a Strong Momentum Stock: Buy Now? - Nasdaq

Click here to get full coverage on Verona Pharma: A Blockbuster Franchise In The Making - Seeking Alpha

Verona Pharma: A Blockbuster Franchise In The Making  Seeking Alpha

Verona Pharma: A Blockbuster Franchise In The Making - Seeking Alpha

Click here to get full coverage on New Analyst Forecast: $VRNA Given 'Overweight' Rating - Quiver Quantitative

New Analyst Forecast: $VRNA Given 'Overweight' Rating  Quiver Quantitative

New Analyst Forecast: $VRNA Given 'Overweight' Rating - Quiver Quantitative

Click here to get full coverage on Verona Pharma plc (NASDAQ:VRNA): When Will It Breakeven? - simplywall.st

Verona Pharma plc (NASDAQ:VRNA): When Will It Breakeven?  simplywall.st

Verona Pharma plc (NASDAQ:VRNA): When Will It Breakeven? - simplywall.st

Click here to get full coverage on Stocks making the biggest moves midday: AES, Nvidia, Bloom Energy, Verona Pharma and more - CNBC

Stocks making the biggest moves midday: AES, Nvidia, Bloom Energy, Verona Pharma and more  CNBC

Stocks making the biggest moves midday: AES, Nvidia, Bloom Energy, Verona Pharma and more - CNBC

Click here to get full coverage on Verona Pharma's Bull Case Holds, But Lifecycle Extension Is Critical - Seeking Alpha

Verona Pharma's Bull Case Holds, But Lifecycle Extension Is Critical  Seeking Alpha

Verona Pharma's Bull Case Holds, But Lifecycle Extension Is Critical - Seeking Alpha

Click here to get full coverage on Stocks making the biggest moves premarket: Starbucks, AES, Verona Pharma, UnitedHealth and more - CNBC

Stocks making the biggest moves premarket: Starbucks, AES, Verona Pharma, UnitedHealth and more  CNBC

Stocks making the biggest moves premarket: Starbucks, AES, Verona Pharma, UnitedHealth and more - CNBC

Click here to get full coverage on New Analyst Forecast: $VRNA Given $107.0 Price Target - Nasdaq

New Analyst Forecast: $VRNA Given $107.0 Price Target  Nasdaq

New Analyst Forecast: $VRNA Given $107.0 Price Target - Nasdaq

Click here to get full coverage on BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verona Pharma plc (Nasdaq - VRNA), Olo Inc. (NYSE - OLO), Guaranty Bancshares, Inc. (NYSE - GNTY), MRC Global Inc. (NYSE - MRC) - Morningstar

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verona Pharma plc (Nasdaq - VRNA), Olo Inc. (NYSE - OLO), Guaranty Bancshares, Inc. (NYSE - GNTY), MRC Global Inc. (NYSE - MRC)  Morningstar

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verona Pharma plc (Nasdaq - VRNA), Olo Inc. (NYSE - OLO), Guaranty Bancshares, Inc. (NYSE - GNTY), MRC Global Inc. (NYSE - MRC) - Morningstar

Click here to get full coverage on Wall Street Analysts See a 30.65% Upside in Verona Pharma (VRNA): Can the Stock Really Move This High? - Yahoo Finance

Wall Street Analysts See a 30.65% Upside in Verona Pharma (VRNA): Can the Stock Really Move This High?  Yahoo Finance

Wall Street Analysts See a 30.65% Upside in Verona Pharma (VRNA): Can the Stock Really Move This High? - Yahoo Finance

Click here to get full coverage on Verona Pharma (VRNA) Jumps 125% YTD; Merck $10-Billion Acquisition Bolsters Sentiment - uk.finance.yahoo.com

Verona Pharma (VRNA) Jumps 125% YTD; Merck $10-Billion Acquisition Bolsters Sentiment  uk.finance.yahoo.com

Verona Pharma (VRNA) Jumps 125% YTD; Merck $10-Billion Acquisition Bolsters Sentiment - uk.finance.yahoo.com

Click here to get full coverage on Verona Pharma Secures Speaking Slots at Two Major Healthcare Investor Conferences This June - Stock Titan

Verona Pharma Secures Speaking Slots at Two Major Healthcare Investor Conferences This June  Stock Titan

Verona Pharma Secures Speaking Slots at Two Major Healthcare Investor Conferences This June - Stock Titan

Click here to get full coverage on Silencing The Doubters: Verona Pharma Could Be Sitting On A Blockbuster (NASDAQ:VRNA) - Seeking Alpha

Silencing The Doubters: Verona Pharma Could Be Sitting On A Blockbuster (NASDAQ:VRNA)  Seeking Alpha

Silencing The Doubters: Verona Pharma Could Be Sitting On A Blockbuster (NASDAQ:VRNA) - Seeking Alpha

Click here to get full coverage on Can VRNA lead its sector in growth - Long-Term Multi-Bagger Outlook - kangso.co.kr

Can VRNA lead its sector in growth - Long-Term Multi-Bagger Outlook  kangso.co.kr

Can VRNA lead its sector in growth - Long-Term Multi-Bagger Outlook - kangso.co.kr

Click here to get full coverage on Verona Pharma PLC (VRNA) Q3 2024 Earnings Call Highlights: Strong Ohtuvayre Launch Amid Rising Costs - Yahoo Finance

Verona Pharma PLC (VRNA) Q3 2024 Earnings Call Highlights: Strong Ohtuvayre Launch Amid Rising Costs  Yahoo Finance

Verona Pharma PLC (VRNA) Q3 2024 Earnings Call Highlights: Strong Ohtuvayre Launch Amid Rising Costs - Yahoo Finance

Click here to get full coverage on Verona Pharma Stock Soars to All-Time High as Merck Buys Firm for $10B - Investopedia

Verona Pharma Stock Soars to All-Time High as Merck Buys Firm for $10B  Investopedia

Verona Pharma Stock Soars to All-Time High as Merck Buys Firm for $10B - Investopedia

Click here to get full coverage on What catalysts could drive VRNA stock higher in 2025 - Phenomenal capital gains - Jammu Links News

What catalysts could drive VRNA stock higher in 2025 - Phenomenal capital gains  Jammu Links News

What catalysts could drive VRNA stock higher in 2025 - Phenomenal capital gains - Jammu Links News

Click here to get full coverage on Zacks Investment Ideas feature highlights: QQQ, IWM, SBET, CRCL, COIN, AES, MRK and VRNA - Yahoo Finance

Zacks Investment Ideas feature highlights: QQQ, IWM, SBET, CRCL, COIN, AES, MRK and VRNA  Yahoo Finance

Zacks Investment Ideas feature highlights: QQQ, IWM, SBET, CRCL, COIN, AES, MRK and VRNA - Yahoo Finance

Click here to get full coverage on Verona Pharma (VRNA) Downgraded Following Merck Acquisition Announcement | VRNA Stock News - GuruFocus

Verona Pharma (VRNA) Downgraded Following Merck Acquisition Announcement | VRNA Stock News  GuruFocus

Verona Pharma (VRNA) Downgraded Following Merck Acquisition Announcement | VRNA Stock News - GuruFocus

Click here to get full coverage on Verona Pharma (VRNA) Skyrockets 20.6% on $10-Billion Merger Deal with Merck - uk.finance.yahoo.com

Verona Pharma (VRNA) Skyrockets 20.6% on $10-Billion Merger Deal with Merck  uk.finance.yahoo.com

Verona Pharma (VRNA) Skyrockets 20.6% on $10-Billion Merger Deal with Merck - uk.finance.yahoo.com

Click here to get full coverage on When (VRNA) Moves Investors should Listen - news.stocktradersdaily.com

When (VRNA) Moves Investors should Listen  news.stocktradersdaily.com

When (VRNA) Moves Investors should Listen - news.stocktradersdaily.com

Click here to get full coverage on Is Verona Pharma (NASDAQ:VRNA) A Risky Investment? - simplywall.st

Is Verona Pharma (NASDAQ:VRNA) A Risky Investment?  simplywall.st

Is Verona Pharma (NASDAQ:VRNA) A Risky Investment? - simplywall.st

Click here to get full coverage on Verona Pharma (VRNA) Jumps 125% YTD; Merck $10-Billion Acquisition Bolsters Sentiment - Insider Monkey

Verona Pharma (VRNA) Jumps 125% YTD; Merck $10-Billion Acquisition Bolsters Sentiment  Insider Monkey

Verona Pharma (VRNA) Jumps 125% YTD; Merck $10-Billion Acquisition Bolsters Sentiment - Insider Monkey

Click here to get full coverage on What Makes Verona Pharma (VRNA) a Good Fit for 'Trend Investing' - Nasdaq

What Makes Verona Pharma (VRNA) a Good Fit for 'Trend Investing'  Nasdaq

What Makes Verona Pharma (VRNA) a Good Fit for 'Trend Investing' - Nasdaq

Click here to get full coverage on What is VRNA company’s growth strategy - Invest confidently with data-driven strategies - Jammu Links News

What is VRNA company’s growth strategy - Invest confidently with data-driven strategies  Jammu Links News

Verona Pharma PLC ADR (VRNA)

Price Chart

Key Statistics

Technicals

About VRNA

Latest News

Verona Pharma plc (VRNA) Is Unlikely To Face Antitrust Action For Merck Deal, Says Jim Cramer - Yahoo Finance

All You Need to Know About Verona Pharma (VRNA) Rating Upgrade to Buy - Nasdaq

Metabolic interference impairs influenza A virus replication by dampening vRNA synthesis - Nature

Advanced Charts

Top Gainers

Top Losers